Showing results (111-120 of 153) with videos related to
Sort By:
Pageof 16
Nature Reviews. Cancer|April 27, 2019
Cancer overdiagnosis: a biological challenge and clinical dilemmaSudhir Srivastava, Eugene J Koay, Alexander D Borowsky, et al.Archives of Internal Medicine|November 28, 2007
Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) studyH Gilbert Welch, Steven Woloshin, Lisa M Schwartz, et al.Journal of the National Cancer Institute|October 12, 2013
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resourceClaire S Zhu, Paul F Pinsky, Barnett S Kramer, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 15, 2013
Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measuresBen Van Calster, Andrew J Vickers, Michael J Pencina, et al.Annals of Family Medicine|May 13, 2009
Cumulative incidence of false-positive results in repeated, multimodal cancer screeningJennifer Miller Croswell, Barnett S Kramer, Aimee R Kreimer, et al.BJU International|January 17, 2007
Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trialPaul F Pinsky, E David Crawford, Barnett S Kramer, et al.The Lancet. Public Health|November 24, 2023
Cancer screening in China: a steep road from evidence to implementationChangfa Xia, Partha Basu, Barnett S Kramer, et al.Gynecologic Oncology|September 13, 2016
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-upPaul F Pinsky, Kelly Yu, Barnett S Kramer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseasesAndrew S Artz, Mark R Somerfield, Jordan J Feld, et al.Journal of the National Cancer Institute|October 1, 2015
Predictive Value Tools as an Aid in Chemopreventive Agent DevelopmentBarbara K Dunn, Vernon E Steele, Richard M Fagerstrom, et al.Pageof 16